IP Library Granted Patent US 9,272,072
Granted Patent B1
US 9,272,072 · App. 14/697,443 · Granted Mar 1, 2016

Osteoinductive bone graft substitute

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,272,072
App. No.
14/697,443
Granted
Mar 1, 2016
Kind
B1
Abstract

An osteoinductive bone graft substitute including an osteoinductive calcium phosphate component retained within a collagen scaffold, wherein the collagen scaffold is formulated to maintain the osteoinductivity of the calcium phosphate component while also exhibiting the following characteristics (1) ability to absorb bone marrow and/or other physiologic liquids, (2) compression resistance; (3) moldability; (4) retaining the calcium phosphate component during and after manipulation of the collagen scaffold and (5) fibrous collagen matrix that retains but does not occlude the osteoinductive calcium phosphate component.

Claims (9)

1. A method of making an osteoinductive bone graft substitute, comprising:

mixing a first soluble collagen solution having a first concentration with osteoinductive calcium phosphate granules to create a slurry;

blending the slurry with a second soluble collagen solution having a second concentration which is greater than the first concentration to create a mixture having a final collagen concentration of 65 mg/g;

pouring the mixture into a mold; and

lyophilizing the mixture.

2. The method of making an osteoinductive bone graft of claim 1 , wherein the first collagen solution has a concentration of 12.5 mg/g.

3. The method of making an osteoinductive bone graft of claim 1 , wherein the second collagen solution has a concentration of 100 mg/g.

4. The method of making an osteoinductive bone graft of claim 1 , wherein the osteoinductive calcium phosphate comprises greater than 90% β-TCP and less than 10% hydroxyapatite.

5. The method of making an osteoinductive bone graft of claim 1 , wherein the osteoinductive calcium phosphate comprises 100% β-TCP.

Assignments (4)
SECURITY INTEREST Recorded Feb 28, 2020
From: NUVASIVE, INC.; NUVASIVE CLINICAL SERVICES MONITORING, INC.; NUVASIVE CLINICAL SERVICES, INC.; NUVASIVE SPECIALIZED ORTHOPEDICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 052918/0595 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded May 17, 2017
From: NUVASIVE, INC.; BIOTRONIC NATIONAL, LLC; NUVASIVE CLINICAL SERVICES MONITORING, INC.; NUVASIVE CLINICAL SERVICES, INC.; NUVASIVE SPECIALIZED ORTHOPEDICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 042490/0236 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Nov 16, 2016
From: NUVASIVE, INC.; IMPULSE MONITORING, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040634/0404 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2015
From: ISMAILOGLU, ALI; VIZESI, FRANK
To: NUVASIVE, INC.
Reel/Frame 036212/0613 →